Difference between revisions of "LncRNAWiki:O"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''OIP5-AS1'' |ENST00000500949.2 |cyrano,LOC729082, linc-NU...") |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 8: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''OIP5-AS1'' | |''OIP5-AS1'' | ||
|[[ENST00000500949.2]] | |[[ENST00000500949.2]] | ||
− | |cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | + | |"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" |
|OIP5 antisense RNA 1 | |OIP5 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''OLMALINC'' | |''OLMALINC'' | ||
|[[OLMALINC]] | |[[OLMALINC]] | ||
− | |bA34D15.5, FLJ12974, HI-LNC80 | + | |"bA34D15.5, FLJ12974, HI-LNC80" |
|oligodendrocyte maturation-associated long intergenic non-coding RNA | |oligodendrocyte maturation-associated long intergenic non-coding RNA | ||
+ | |_ | ||
|- | |- | ||
|''OTX2-AS1'' | |''OTX2-AS1'' | ||
|[[lnc-C14orf101-5:1]] | |[[lnc-C14orf101-5:1]] | ||
− | |OTX2OS1, ENSG00000248550 | + | |"OTX2OS1, ENSG00000248550" |
|OTX2 antisense RNA 1 (head to head) | |OTX2 antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''OVAAL'' | |''OVAAL'' | ||
|[[ENST00000442621.1]] | |[[ENST00000442621.1]] | ||
− | |LINC01131,OVAL | + | |"LINC01131,OVAL" |
|ovarian adenocarcinoma amplified long non-coding RNA | |ovarian adenocarcinoma amplified long non-coding RNA | ||
+ | |ovarian cancer | ||
+ | |- | ||
+ | |''PAX8-AS1'' | ||
+ | |[[PAX8-AS1]] | ||
+ | |N/A | ||
+ | |PAX8 antisense RNA 1 | ||
+ | |cervical cancer | ||
+ | |- | ||
+ | |''PINCR'' | ||
+ | |[[PINCR]] | ||
+ | |N/A | ||
+ | |p53-induced noncoding RNA | ||
+ | |Colorectal cancer | ||
+ | |- | ||
+ | |''PLUT'' | ||
+ | |[[PLUT]] | ||
+ | |PDX1-AS1, PLUTO, HI-LNC71 | ||
+ | |PDX1 associated lncRNA, upregulator of transcription | ||
+ | |Type 2 diabetes | ||
+ | |- | ||
+ | |''PRAL'' | ||
+ | |[[PRAL]] | ||
+ | |lncRNA-PRAL | ||
+ | |p53 regulation associated lncRNA | ||
+ | |Hepatocellular carcinoma, Lung Cancer | ||
+ | |- | ||
+ | |''PRKCZ-AS1'' | ||
+ | |[[PRKCZ-AS1]] | ||
+ | |RP11-181G12.2 | ||
+ | |PRKCZ antisense RNA 1 | ||
+ | |lung adenocarcinoma | ||
+ | |- | ||
+ | |''PRKG1-AS1'' | ||
+ | |[[PRKG1-AS1]] | ||
+ | |RP11-573I11.2 | ||
+ | |PRKG1 antisense RNA 1 | ||
+ | |rheumatoid arthritis | ||
+ | |- | ||
+ | |''PSMD6-AS1'' | ||
+ | |[[PSMD6-AS1]] | ||
+ | |ENST00000462717, lnc00462717 | ||
+ | |PSMD6 antisense RNA 1 | ||
+ | |Papillary Thyroid Cancer, GBM | ||
+ | |- | ||
+ | |''PSORS1C3'' | ||
+ | |[[PSORS1C3]] | ||
+ | |NCRNA00196 | ||
+ | |psoriasis susceptibility 1 candidate 3 (non-protein coding) | ||
+ | |rheumatoid arthritis | ||
+ | |- | ||
+ | |''PSPC1-AS2'' | ||
+ | |[[PSPC1-AS2]] | ||
+ | |RP11-523H24.3 | ||
+ | |PSPC1 antisense RNA 2 | ||
+ | |esophageal squamous cell carcinoma | ||
|} | |} |
Latest revision as of 09:28, 29 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
OIP5-AS1 | ENST00000500949.2 | "cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" | OIP5 antisense RNA 1 | _ |
OLMALINC | OLMALINC | "bA34D15.5, FLJ12974, HI-LNC80" | oligodendrocyte maturation-associated long intergenic non-coding RNA | _ |
OTX2-AS1 | lnc-C14orf101-5:1 | "OTX2OS1, ENSG00000248550" | OTX2 antisense RNA 1 (head to head) | _ |
OVAAL | ENST00000442621.1 | "LINC01131,OVAL" | ovarian adenocarcinoma amplified long non-coding RNA | ovarian cancer |
PAX8-AS1 | PAX8-AS1 | N/A | PAX8 antisense RNA 1 | cervical cancer |
PINCR | PINCR | N/A | p53-induced noncoding RNA | Colorectal cancer |
PLUT | PLUT | PDX1-AS1, PLUTO, HI-LNC71 | PDX1 associated lncRNA, upregulator of transcription | Type 2 diabetes |
PRAL | PRAL | lncRNA-PRAL | p53 regulation associated lncRNA | Hepatocellular carcinoma, Lung Cancer |
PRKCZ-AS1 | PRKCZ-AS1 | RP11-181G12.2 | PRKCZ antisense RNA 1 | lung adenocarcinoma |
PRKG1-AS1 | PRKG1-AS1 | RP11-573I11.2 | PRKG1 antisense RNA 1 | rheumatoid arthritis |
PSMD6-AS1 | PSMD6-AS1 | ENST00000462717, lnc00462717 | PSMD6 antisense RNA 1 | Papillary Thyroid Cancer, GBM |
PSORS1C3 | PSORS1C3 | NCRNA00196 | psoriasis susceptibility 1 candidate 3 (non-protein coding) | rheumatoid arthritis |
PSPC1-AS2 | PSPC1-AS2 | RP11-523H24.3 | PSPC1 antisense RNA 2 | esophageal squamous cell carcinoma |